Global Diagnostic Tests Market, By Type (Routine Tests and Specialized Tests), Component (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gen Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Application (Oncology, Cardiology, Orthopedics, Gastroenterology, Gynecology, Neurology, Odontology, and Others), Sample Type (Blood, Urine, Saliva, Sweat, Hair, and Others), Testing Site (Laboratory Based Testing and At Home Testing), Testing Type (Biochemistry, Hematology, Microbiology, Histopathology, and Others), Age (Geriatric, Adult, and Pediatric), End User (Hospitals, Diagnostic Center, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Homecare, Blood Banks, Research Labs & Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Online Sales) - Industry trends and forecast to 2031.
Diagnostic Tests Market Analysis and Size
One of the primary factors driving the growth of the market is the rising prevalence of chronic diseases. In addition, the rising number of IVD tests conducted across the globe is another key driver for market growth. Favorable reimbursement policies also influence the market. However high cost associated with diagnostic kits is restraining the market growth. Strategic initiatives by the market players act as an opportunity for market growth. However, stringent rules and regulations for the approval of diagnostic test kits may create a challenge for the market.
Data Bridge Market Research analyzes that the global diagnostic tests market is expected to reach the value of USD 495.85 billion by 2031, from USD 264.17 billion in 2023, growing at a CAGR of 8.4% during the forecast period of 2024 to 2031.
Report Metric |
Details |
Forecast Period |
2024 to 2031 |
Base Year |
2023 |
Historic Years |
2022 (Customizable to 2016-2021) |
Quantitative Units |
Revenue in USD Billion |
Segments Covered |
Type (Routine Tests and Specialized Tests), Component (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gen Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Application (Oncology, Cardiology, Orthopedics, Gastroenterology, Gynecology, Neurology, Odontology, and Others), Sample Type (Blood, Urine, Saliva, Sweat, Hair, and Others), Testing Site (Laboratory Based Testing and At Home Testing), Testing Type (Biochemistry, Hematology, Microbiology, Histopathology, and Others), Age (Geriatric, Adult, and Pediatric), End User (Hospitals, Diagnostic Center, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Homecare, Blood Banks, Research Labs & Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Online Sales) |
Countries Covered |
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Turkey, Netherlands, Switzerland, Norway, Hungary, Austria, Lithuania, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Malaysia, Singapore, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Colombia, Venezuela, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, and Rest of Middle East and Africa |
Market Players Covered |
F. Hoffmann-La Roche Ltd, Abbott, Danaher, Siemens Healthineers AG, BD, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., EKF Diagnostics, ACON Laboratories, Inc., and BIOMEDOMICS INC. among others |
Market Definition
Diagnostic tests are medical procedures or devices designed to identify and determine the presence or absence of specific diseases, conditions, or markers in individuals. These tests play a crucial role in healthcare by aiding in the early detection, diagnosis, and monitoring of various medical conditions.
Global Diagnostic Tests Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing Prevalence of Chronic Diseases
The encumbrance of chronic disease is continuously increasing across the globe. According to the WHO (World Health Organization), during 2021, the contribution of chronic disease was about 60%, which accounted for the number of deaths. In most Western countries, the increase in the number of chronic diseases is due to the rise in the number of the aged population. These increasing rates of diseases are directly proportional to the growth of diagnostics tests, as they are used to diagnose almost all diseases.
As the rate of chronic disease grows with time, the factors associated with the disease rates also increase. With the increase of disease, the healthcare and the status of health is also improving over time, and this is due to the adoption and increase in diagnosis of multiple chronic diseases.
The increasing prevalence of chronic diseases worldwide is a major driving force behind the growth of the diagnostic tests market. The need for accurate, timely, and personalized diagnostics to manage chronic conditions effectively fuels innovation in diagnostic technologies and promotes the expansion of the diagnostic tests market to meet the evolving healthcare demands.
- Rising Number of IVD Tests Conducted Across the Globe
In vitro diagnostics are one of the most significant segments in the healthcare industry. They are considered to be the most significant tool in the diagnostic world that help in the early diagnosis and prevention of diseases that affect the emotional, and personal life of the patient and also drain out financially. They are used in the diagnosis of cancer the prediction of associated risks, and others.
由于早期发现疾病而导致的依赖性增加,以及由于 IVD 测试数量的增加而导致的在疾病出现之前预测疾病和预测治疗的不良影响的能力的进步正在推动市场增长
机会
- 市场参与者的战略举措
随着老年人口的增加,各地区慢性和非慢性疾病负担的增加,对开发具有更好功效和更少时间消耗的新型诊断试剂盒和解决方案的需求也随之增加。他们的主要目标是改善健康管理和诊断,以提高质量。他们的首要任务是支持医疗保健终端用户进行诊断,以便做出更好的结构性决策。市场参与者正忙于满足医疗保健专业人士的需求,并花费大量资金购买更好的产品、试剂盒和试剂等。
政府的这些战略举措,包括收购和针对不同细分市场的重点产品发布,正在帮助他们扩大全球影响力,同时也帮助他们扩大和增强公司的产品组合,最终将带来更多的收入,因此市场参与者的这些战略举措正在成为市场增长的机会。
克制/挑战
- 诊断试剂盒审批的规则和规定十分严格
随着老龄人口的增长以及多种可通过早期诊断预防的疾病,全球范围内诊断试剂盒的使用正在迅速增加。同时,市场上诊断试剂盒和试剂的参与者必须遵守某些规定,才能获得上级部门的批准,才能将产品推向市场。必须遵循这些严格的指导方针,这是所有步骤中最困难的任务之一。
美国 FDA 对 DNA 检测试剂盒的监管确保了诊断试剂盒的有效性和安全性,即使在制造和储存试剂盒时也有具体的指导方针;这是参与者面临的主要挑战之一,因为试剂盒需要储存在 -18 至 -80 摄氏度的温度范围内。如果 FDA 发现这些指导方针没有得到强制执行或遵守,他们可能会禁止试剂盒,这被认为是最严格的指导方针之一。
FDA 的这些指导方针是对参与者最具挑战性的任务之一,同时也限制了其他新参与者进入市场。为了满足这些指导方针,需要大量的资本,而这对于中低端参与者来说很难维持,从而阻碍了增长并对全球诊断市场构成了挑战。
最新动态
- 2023 年 5 月,罗氏正式宣布收购 Stratos Genomics。此次收购推动了用于诊断的 DNA 测序的发展。这增强了公司的医疗诊断部门,从而带来了更多的收入
- 2022 年 4 月,Bio-Rad Laboratories, Inc. 正式宣布收购 Celsee, Inc.,该公司提供用于分析细胞并有助于诊断的仪器。此次收购为双方创造了推出新产品的机会,这将改善公司的产品组合
- 2022 年 9 月,雅培推出 FreeStyle Libre 3 传感器,彻底改变了连续血糖监测 (CGM)。该传感器拥有 14 天的佩戴时间,无需刺破手指,可提供患者的实时血糖数据,从而更好地管理糖尿病。Libre 3 延长了佩戴时间,改善了用户体验,解决了糖尿病患者的主要痛点,有可能提高市场份额和患者满意度。
- 2020 年 3 月,罗氏获得 FDA 批准 Elecsys GALAD。此项批准增强了公司的产品部门,并有助于癌症的早期诊断。此项批准还增强了公司的财务状况
- 2020 年 3 月,Bio-Rad Laboratories, Inc. 正式宣布与 Testing Labs Worldwide 建立合作伙伴关系。此次合作有助于诊断包括 COVID-19 在内的各种疾病。这有助于增强公司的产品组合。
全球诊断测试市场范围
全球诊断测试市场根据类型、组件、技术、测试模式、应用、样本类型、测试地点、测试类型、年龄、最终用户和分销渠道细分为 11 个值得注意的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
类型
- 常规检查
- 专门测试
根据类型,全球诊断测试市场分为常规测试和专门测试。
成分
- 服务
- 产品
根据组成部分,全球诊断测试市场分为服务和产品。
技术
- 基于免疫测定
- 基于PCR
- 下一代测序
- 基于光谱的
- 基于色谱法
- 微流体
- 其他的
根据技术,全球诊断测试市场分为基于免疫测定、基于 PCR、下一代测序、基于光谱、基于色谱、微流体等。
测试方式
- 基于处方的测试
- OTC测试
根据测试模式,全球诊断测试市场分为处方测试和非处方测试。
应用
- 肿瘤学
- 心脏病学
- 骨科
- 胃肠病学
- 妇科
- 神经病学
- 牙科
- 其他的
根据应用,全球诊断测试市场分为肿瘤学、心脏病学、骨科、胃肠病学、妇科、神经病学、牙科学等。
样品类型
- 血
- 尿
- 唾液
- 汗
- 头发
- 其他的
根据样本类型,全球诊断测试市场分为血液、尿液、唾液、汗液、头发和其他。
测试地点
- 实验室测试
- 在家测试
根据测试地点,全球诊断测试市场分为实验室测试和家庭测试。
测试类型
- 生物化学
- 血液学
- 微生物学
- 组织病理学
- 其他的
根据测试类型,全球诊断测试市场分为生物化学、血液学、微生物学、组织病理学等。
年龄
- 老年
- 成人
- 儿科
根据年龄,全球诊断测试市场分为老年人、成人和儿童。
最终用户
- 医院
- 诊断中心
- 门诊手术中心 (ASC)
- 专科诊所
- 家庭护理
- 血库
- 研究实验室和研究所
- 其他的
根据最终用户,全球诊断测试市场分为医院、诊断中心、门诊手术中心 (ASC)、专科诊所、家庭护理、血库、研究实验室和研究所等。
分销渠道
- 直接招标
- 零售销售
- 网上销售
根据分销渠道,全球诊断测试市场分为直接招标、零售和在线销售。
全球诊断测试市场:区域分析/见解
对全球诊断测试市场进行分析,并按国家、类型、组件、技术、测试模式、应用、样本类型、测试地点、测试类型、年龄、最终用户和分销渠道提供市场规模洞察和趋势。
本市场报告涵盖的国家包括美国、加拿大、墨西哥、德国、英国、法国、意大利、西班牙、俄罗斯、波兰、土耳其、荷兰、瑞士、挪威、匈牙利、奥地利、立陶宛、爱尔兰、欧洲其他地区、中国、日本、印度、韩国、澳大利亚、马来西亚、新加坡、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、巴西、阿根廷、秘鲁、哥伦比亚、委内瑞拉、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、科威特以及中东和非洲其他地区。
由于慢性病的发病率不断上升,北美有望主导全球诊断测试市场。由于各制造商的投资水平较高,且该地区对药品制造的需求不断增加,美国有望主导北美诊断测试市场。由于慢性病和传染病的发病率不断上升,德国有望主导欧洲诊断测试市场。由于全球 IVD 测试数量不断增加,中国有望主导亚太诊断测试市场。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在对国家数据进行预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响以及贸易路线。
全球诊断测试市场:竞争格局和份额分析
全球诊断测试市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
全球诊断测试市场的一些主要市场参与者包括 F. Hoffmann-La Roche Ltd、Abbott、Danaher、Siemens Healthineers AG、BD、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc.、EKF Diagnostics、ACON Laboratories, Inc. 和 BIOMEDOMICS INC. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL DIAGNOSTIC TESTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES
5 GLOBAL DIAGNOSTIC TESTS MARKET: REGULATIONS
5.1 REGULATIONS IN U.S.
5.2 REGULATIONS IN EUROPE
5.3 REGULATTIONS IN AUSTRALIA
5.4 REGULATTIONS IN SOUTH AFRICA
5.5 REGULATIONS IN BRAZIL
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 RISING NUMBER OF IVD TESTS CONDUCTED ACROSS THE GLOBE
6.1.3 FAVORABLE REIMBURSEMENT POLICIES
6.1.4 IMPROVING DIAGNOSIS SEEKING RATE ACROSS THE GLOBE
6.2 RESTRAINTS
6.2.1 HIGH COST ASSOCIATED WITH DIAGNOSTIC KITS
6.2.2 LACK OF TRAINED LABORATORY PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
6.3.2 EXPANDING BUSINESS THROUGH SUBSIDIARIES
6.3.3 RISING AWARENESS AND GOVERNMENT FUNDING
6.4 CHALLENGES
6.4.1 STRINGENT RULES AND REGULATIONS FOR THE APPROVAL OF DIAGNOSTIC TEST KITS
6.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS
7 GLOBAL DIAGNOSTIC TESTS MARKET, BY TYPE
7.1 OVERVIEW
7.2 ROUTINE TESTS
7.3 SPECIALIZED TESTS
8 GLOBAL DIAGNOSTIC TESTS MARKET, BY COMPONENT
8.1 OVERVIEW
8.2 SERVICES
8.3 PRODUCT
9 GLOBAL DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 IMMUNOASSAY-BASED
9.3 PCR BASED
9.4 NEXT GEN SEQUENCING
9.5 CANNULA
9.6 CHROMATOGRAPHY BASED
9.7 MICROFLUIDICS
9.8 OTHERS
10 GLOBAL DIAGNOSTIC TESTS MARKET, BY MODE OF TESTING
10.1 OVERVIEW
10.2 PRESCRIPTION-BASED TESTING
10.3 OTC TESTING
11 GLOBAL DIAGNOSTIC TESTS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ONCOLOGY
11.3 CARDIOLOGY
11.4 ORTHOPEDICS
11.5 GASTROENTROLOGY
11.6 GYNECOLOGY
11.7 NEUROLOGY
11.8 ODONTOLOGY
11.9 OTHERS
12 GLOBAL DIAGNOSTIC TESTS MARKET, BY SAMPLE TYPE
12.1 OVERVIEW
12.2 BLOOD
12.3 URINE
12.4 SALIVA
12.5 SWEAT
12.6 HAIR
12.7 OTHERS
13 GLOBAL DIAGNOSTIC TESTS MARKET, BY TESTING SITE
13.1 OVERVIEW
13.2 LABORATORY BASED TESTING
13.3 AT HOME TESTING
14 GLOBAL DIAGNOSTIC TESTS MARKET, BY TESTING TYPE
14.1 OVERVIEW
14.2 BIOCHEMISTRY
14.3 HEMATOLOGY
14.4 MICROBIOLOGY
14.5 HISTOPATHOLOGY
14.6 OTHERS
15 GLOBAL DIAGNOSTIC TESTS MARKET, BY AGE
15.1 OVERVIEW
15.2 GERIATRIC
15.3 ADULT
15.4 PEDIATRIC
16 GLOBAL DIAGNOSTIC TESTS MARKET, BY END USER
16.1 OVERVIEW
16.2 HOSPITALS
16.3 DIAGNOSTIC CENTER
16.4 AMBULATORY SURGICAL CENTERS (ASCS)
16.5 SPECIALTY CLINICS
16.6 HOME CARE
16.7 BLOOD BANKS
16.8 RESEARCH LABS AND INSTITUTES
16.9 OTHERS
17 GLOBAL DIAGNOSTIC TESTS MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT TENDERS
17.3 RETAIL SALES
17.4 ONLINE SALES
18 GLOBAL DIAGNOSTIC TESTS MARKET, BY REGION
18.1 OVERVIEW
18.2 NORTH AMERICA
18.2.1 U.S.
18.2.2 CANADA
18.2.3 MEXICO
18.3 EUROPE
18.3.1 GERMANY
18.3.2 U.K.
18.3.3 FRANCE
18.3.4 ITALY
18.3.5 SPAIN
18.3.6 RUSSIA
18.3.7 POLAND
18.3.8 TURKEY
18.3.9 NETHERLANDS
18.3.10 SWITZERLAND
18.3.11 NORWAY
18.3.12 HUNGARY
18.3.13 AUSTRIA
18.3.14 LITHUANIA
18.3.15 IRELAND
18.3.16 REST OF EUROPE
18.4 ASIA-PACIFIC
18.4.1 CHINA
18.4.2 JAPAN
18.4.3 INDIA
18.4.4 SOUTH KOREA
18.4.5 AUSTRALIA
18.4.6 MALAYSIA
18.4.7 SINGAPORE
18.4.8 THAILAND
18.4.9 INDONESIA
18.4.10 PHILIPPINES
18.4.11 VIETNAM
18.4.12 REST OF ASIA-PACIFIC
18.5 SOUTH AMERICA
18.5.1 BRAZIL
18.5.2 ARGENTINA
18.5.3 PERU
18.5.4 COLOMBIA
18.5.5 VENEZUELA
18.5.6 REST OF SOUTH AMERICA
18.6 MIDDLE EAST AND AFRICA
18.6.1 SOUTH AFRICA
18.6.2 SAUDI ARABIA
18.6.3 U.A.E.
18.6.4 EGYPT
18.6.5 ISRAEL
18.6.6 KUWAIT
18.6.7 REST OF MIDDLE EAST AND AFRICA
19 GLOBAL DIAGNOSTIC TESTS MARKET, COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: GLOBAL
19.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
19.3 COMPANY SHARE ANALYSIS: EUROPE
19.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20 COMPANY PROFILE
20.1 F. HOFFMANN-LA ROCHE LTD.
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 ABBOTT
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 DANAHER
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 COMPANY SHARE ANALYSIS
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENTS
20.4 SIEMENS HEALTHCARE GMBH
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 BD
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 ACON LABORATORIES INC.
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENTS
20.7 BIO-RAD LABORATORIES, INC.
20.7.1 COMPANY SNAPSHOT
20.7.2 REVENUE ANALYSIS
20.7.3 PRODUCT PORTFOLIO
20.7.4 RECENT DEVELOPMENTS
20.8 BIOMEDOMICS INC.
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENTS
20.9 EKF DIAGNOSTICS
20.9.1 COMPANY SNAPSHOT
20.9.2 REVENUE ANALYSIS
20.9.3 PRODUCT PORTFOLIO
20.9.4 RECENT DEVELOPMENTS
20.1 THERMOFISHER
20.10.1 COMPANY SNAPSHOT
20.10.2 REVENUE ANALYSIS
20.10.3 PRODUCT PORTFOLIO
20.10.4 RECENT DEVELOPMENTS
21 QUESTIONNAIRE
22 RELATED REPORTS
表格列表
TABLE 1 INDICATIVE REIMBURSEMENT FOR IN VITRO DIAGNOSTIC TESTS – U.S.
TABLE 2 COST OF DIAGNOSTICS
TABLE 3 THERMO FISHER SCIENTIFIC INC.,
TABLE 4 DANAHER CORPORATION,
TABLE 5 ABBOTT,
TABLE 6 DIFFERENT ASSOCIATIONS FOR DIAGNOSTICS
TABLE 7 GLOBAL DIAGNOSTIC TESTS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 GLOBAL ROUTINE TEST IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 9 GLOBAL ROUTINE TESTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 10 GLOBAL SPECIALIZED TESTS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 11 GLOBAL SPECIALIZED TESTS IN DIAGNOSTIC TESTS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 GLOBAL DIAGNOSTIC TESTS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 13 GLOBAL SERVICES IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 14 GLOBAL PRODUCT IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 GLOBAL DIAGNOSTIC TESTS MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND)
TABLE 16 GLOBAL IMMUNOASSAY-BASED IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 GLOBAL PCR-BASED IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 18 GLOBAL NEXT GENE SEQUENCING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 GLOBAL SPECTROSCOPY-BASED IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 GLOBAL CHROMATOGRAPHY-BASED IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 GLOBAL MICROFLUIDICS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 22 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 23 GLOBAL DIAGNOSTIC TESTS MARKET, BY MODE OF TESTING, 2022-2031 (USD THOUSAND)
TABLE 24 GLOBAL PRESCRIPTION-BASED TESTING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 25 GLOBAL OTC TESTING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 26 GLOBAL DIAGNOSTIC TESTS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 27 GLOBAL ONCOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 GLOBAL CARDIOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 GLOBAL ORTHOPEDICS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 30 GLOBAL GASTROENTROLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 GLOBAL GYNECOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 32 GLOBAL NEUROLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 GLOBAL ODONTOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 35 GLOBAL DIAGNOSTIC TESTS MARKET, BY SAMPLE TYPE, 2022-2031 (USD THOUSAND)
TABLE 36 GLOBAL BLOOD IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 37 GLOBAL URINE IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 38 GLOBAL SALIVA IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 39 GLOBAL SWEAT IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 40 GLOBAL HAIR IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 41 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 42 GLOBAL DIAGNOSTIC TESTS MARKET, BY TESTING SITE, 2022-2031 (USD THOUSAND)
TABLE 43 GLOBAL LABORATORY BASED TESTING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 44 GLOBAL AT HOME TESTING IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 45 GLOBAL DIAGNOSTIC TESTS MARKET, BY TESTING TYPE, 2022-2031 (USD THOUSAND)
TABLE 46 GLOBAL BIOCHEMISTRY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 47 GLOBAL HEMATOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 48 GLOBAL MICROBIOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 49 GLOBAL HISTOPATHOLOGY IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 50 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 51 GLOBAL DIAGNOSTIC TESTS MARKET, BY AGE, 2022-2031 (USD THOUSAND)
TABLE 52 GLOBAL GERIATRIC IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 53 GLOBAL ADULT IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 54 GLOBAL PEDIATRIC IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 55 GLOBAL DIAGNOSTIC TESTS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 56 GLOBAL HOSPITALS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 57 GLOBAL DIAGNOSTIC CENTER IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 58 GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 59 GLOBAL SPECIALTY CLINICS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 60 GLOBAL HOME CARE IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 61 GLOBAL BLOOD BANKS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 62 GLOBAL RESEARCH LABS AND INSTITUTES IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 63 GLOBAL OTHERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 64 GLOBAL DIAGNOSTIC TESTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 65 GLOBAL DIRECT TENDERS IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 66 GLOBAL RETAIL SALES IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 67 GLOBAL ONLINE SALES IN DIAGNOSTIC TESTS MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 68 GLOBAL DIAGNOSTIC TESTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
图片列表
FIGURE 1 GLOBAL DIAGNOSTIC TESTS MARKET: SEGMENTATION
FIGURE 2 GLOBAL DIAGNOSTIC TESTS MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL DIAGNOSTIC TESTS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL DIAGNOSTIC TESTS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL DIAGNOSTIC TESTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL DIAGNOSTIC TESTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL DIAGNOSTIC TESTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 GLOBAL DIAGNOSTIC TESTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL DIAGNOSTIC TESTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL DIAGNOSTIC TESTS MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL DIAGNOSTIC TESTS MARKET FROM 2024 TO 2031
FIGURE 12 ROUTINE TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL DIAGNOSTIC TESTS MARKET IN 2024 TO 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL DIAGNOSTIC TESTS MARKET AND ASIA-APCIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL DIAGNOSTICS TESTS MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL DIAGNOSTIC TESTS MARKET
FIGURE 16 GLOBAL DIAGNOSTIC TESTS MARKET: BY TYPE, 2022
FIGURE 17 GLOBAL DIAGNOSTIC TESTS MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 18 GLOBAL DIAGNOSTIC TESTS MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 19 GLOBAL DIAGNOSTIC TESTS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 GLOBAL DIAGNOSTIC TESTS MARKET: BY COMPONENT, 2022
FIGURE 21 GLOBAL DIAGNOSTIC TESTS MARKET: BY COMPONENT, 2024-2031 (USD THOUSAND)
FIGURE 22 GLOBAL DIAGNOSTIC TESTS MARKET: BY COMPONENT, CAGR (2024-2031)
FIGURE 23 GLOBAL DIAGNOSTIC TESTS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 24 GLOBAL DIAGNOSTIC TESTS MARKET: BY TECHNOLOGY, 2023
FIGURE 25 GLOBAL DIAGNOSTIC TESTS MARKET: BY TECHNOLOGY, 2024-2031 (USD THOUSAND)
FIGURE 26 GLOBAL DIAGNOSTIC TESTS MARKET: BY TECHNOLOGY, CAGR (2024-2031)
FIGURE 27 GLOBAL DIAGNOSTIC TESTS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 GLOBAL DIAGNOSTIC TESTS MARKET: BY MODE OF TESTING, 2022
FIGURE 29 GLOBAL DIAGNOSTIC TESTS MARKET: BY MODE OF TESTING, 2024-2031 (USD THOUSAND)
FIGURE 30 GLOBAL DIAGNOSTIC TESTS MARKET: BY MODE OF TESTING, CAGR (2024-2031)
FIGURE 31 GLOBAL DIAGNOSTIC TESTS MARKET: BY MODE OF TESTING, LIFELINE CURVE
FIGURE 32 GLOBAL DIAGNOSTIC TESTS MARKET: BY APPLICATION, 2022
FIGURE 33 GLOBAL DIAGNOSTIC TESTS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 34 GLOBAL DIAGNOSTIC TESTS MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 35 GLOBAL DIAGNOSTIC TESTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 36 GLOBAL DIAGNOSTIC TESTS MARKET: BY SAMPLE TYPE, 2022
FIGURE 37 GLOBAL DIAGNOSTIC TESTS MARKET: BY SAMPLE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 38 GLOBAL DIAGNOSTIC TESTS MARKET: BY SAMPLE TYPE, CAGR (2024-2031)
FIGURE 39 GLOBAL DIAGNOSTIC TESTS MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 40 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING SITE, 2022
FIGURE 41 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING SITE, 2024-2031 (USD THOUSAND)
FIGURE 42 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING SITE, CAGR (2024-2031)
FIGURE 43 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING SITE, LIFELINE CURVE
FIGURE 44 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING TYPE, 2022
FIGURE 45 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING TYPE, 2024-2031 (USD THOUSAND)
FIGURE 46 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING TYPE, CAGR (2024-2031)
FIGURE 47 GLOBAL DIAGNOSTIC TESTS MARKET: BY TESTING TYPE, LIFELINE CURVE
FIGURE 48 GLOBAL DIAGNOSTIC TESTS MARKET: BY AGE, 2022
FIGURE 49 GLOBAL DIAGNOSTIC TESTS MARKET: BY AGE, 2024-2031 (USD THOUSAND)
FIGURE 50 GLOBAL DIAGNOSTIC TESTS MARKET: BY AGE, CAGR (2024-2031)
FIGURE 51 GLOBAL DIAGNOSTIC TESTS MARKET: BY AGE, LIFELINE CURVE
FIGURE 52 GLOBAL DIAGNOSTIC TESTS MARKET: BY END USER, 2023
FIGURE 53 GLOBAL DIAGNOSTIC TESTS MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 54 GLOBAL DIAGNOSTIC TESTS MARKET: BY END USER, CAGR (2024-2031)
FIGURE 55 GLOBAL DIAGNOSTIC TESTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 56 GLOBAL DIAGNOSTIC TESTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 57 GLOBAL DIAGNOSTIC TESTS MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 58 GLOBAL DIAGNOSTIC TESTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 59 GLOBAL DIAGNOSTIC TESTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 60 GLOBAL DIAGNOSTIC TESTS MARKET: SNAPSHOT (2023)
FIGURE 61 GLOBAL DIAGNOSTIC TESTS MARKET: COMPANY SHARE 2022 (%)
FIGURE 62 NORTH AMERICA DIAGNOSTIC TESTS MARKET: COMPANY SHARE 2022 (%)
FIGURE 63 EUROPE DIAGNOSTIC TESTS MARKET: COMPANY SHARE 2023 (%)
FIGURE 64 ASIA-PACIFIC DIAGNOSTIC TESTS MARKET: COMPANY SHARE 2023 (%)

研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。